** ClearPoint Neuro Inc CLPT.O shares down ~6% premarket
after co prices follow-on
** Medical device co sells ~1.9 mln shares at $23.50, raises
~$43.5 mln to fund product development, R&D and for working
capital and general corp purposes urn:newsml:reuters.com:*:nGNX9sFcvl
** Offering prices at ~9% discount to stock's Thurs close
** Deal size represents ~16% of CLPT's free float, per
Refinitiv data
** B. Riley sole bookrunner
** Last Fri, CLPT's stock rose 14% to $28.99 after co
announced multi-product partnership with Blackrock Microsystems
BLK.N to enter neurosurgery markets urn:newsml:reuters.com:*:nGNX97TG7N
** CLPT shares are up 62% YTD and have surged >500% over the
past 6 months
(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper.tr.com@reuters.net
lance.tupper@tr.com 1-332-219-1430))